Lyme disease antiscience – Authors’ reply - 26/04/12
Doi : 10.1016/S1473-3099(12)70056-7
Paul G Auwaerter a 
, Johan S Bakken b, Raymond J Dattwyler c, John J Halperin e, f, Robert B Nadelman d, Susan O’Connell g, Eugene D Shapiro h, Arthur Weinstein i, Gary P Wormser d
, Johan S Bakken b, Raymond J Dattwyler c, John J Halperin e, f, Robert B Nadelman d, Susan O’Connell g, Eugene D Shapiro h, Arthur Weinstein i, Gary P Wormser d a Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA
b Section of Infectious Diseases, St Luke’s Hospital, Duluth, MN, USA
c Division of Allergy, Immunology and Rheumatology, New York Medical College, Valhalla, NY, USA
d Division of Infectious Diseases, New York Medical College, Valhalla, NY, USA
e Department of Medicine, New York Medical College, Valhalla, NY, USA
f Atlantic Neuroscience Institute, Summit, NJ, USA
g Lyme Borreliosis Unit, Health Protection Agency Microbiology Laboratory, Southampton General Hospital, Southampton, UK
h Department of Pediatrics, Department of Epidemiology and Public Health, and Department of Investigative Medicine, Yale University, New Haven, CT, USA
i Section of Rheumatology, Department of Medicine, Washington Hospital Center and Georgetown University Medical Center, Washington, DC, USA
Le texte complet de cet article est disponible en PDF.
© 2012
Elsevier Ltd. Tous droits réservés.
Vol 12 - N° 5
P. 362-363 - mai 2012 Retour au numéro
Article précédent
- Lyme disease antiscience
- Carl Tuttle
- Post-disaster assessment in Brazzaville, Congo
- François-Xavier Mbopi-Kéou
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?